Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Vera Therapeutics (VERA) SEC Filings & 10K Form

Vera Therapeutics logo
$22.57 -0.04 (-0.18%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$22.55 -0.02 (-0.09%)
As of 08/22/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Vera Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
10:00 AM		Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
Form SCHEDULE 13G
08/05/2025
3:53 PM		Vera Therapeutics (Filer)
Form 424B5
08/05/2025
6:30 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025
7:07 PM		ENRIGHT PATRICK G (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:38 PM		Flynn James E (Filed by)
Vera Therapeutics (Subject)
Form SCHEDULE 13G
06/03/2025
5:36 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
5:36 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:00 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
3:44 PM		Vera Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:21 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
7:00 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
3:05 PM		JOHNSON DAVID LEE (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:07 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:08 PM		Grant Sean (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:10 PM		Brenner Robert (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
8:30 AM		Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:06 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:22 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
3:24 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:59 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
3:05 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:40 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
11:15 AM		Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:35 AM		Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G
11/12/2024
9:34 AM		FMR LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
11/07/2024
7:00 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
6:49 PM		Longitude Capital Partners IV, LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13D/A
10/31/2024
5:05 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:15 PM		Vera Therapeutics (Filer)
Form 424B5
10/29/2024
5:15 AM		Vera Therapeutics (Filer)
Form 424B5
10/28/2024
4:29 PM		Vera Therapeutics (Filer)
Form S-3ASR
10/28/2024
4:30 PM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:37 PM		SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:16 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:05 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:17 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
8:01 AM		Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:05 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:45 PM		SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:38 PM		SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:38 PM		SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Alex’s “Next Magnificent Seven” stocks (Ad)

The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.tc pixel

Watch the “Next Magnificent Seven” presentation here
09/13/2024
3:36 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:19 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:04 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:40 PM		Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VERA) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsoredtc pixel
Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...
Brownstone Research | Sponsoredtc pixel